Industries > Pharma > Collagen Market Report 2019-2029

Collagen Market Report 2019-2029

Revenue Prospects for Source, Product and Application

PUBLISHED: 08 April 2019
PAGES: 220
SUBMARKET: Therapeutic Drugs

WOOCS 2.2.1
SKU: PHA0382 Categories: , Tag:

The collagen market is estimated to have reached $3.8bn in 2018 and expected to grow at a CAGR of 8.10% in the first half of the forecast period. The market is dominated by the gelatine segment which held 48% of the collagen market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 220-page report you will receive 256 charts– all unavailable elsewhere.

The 220-page report provides clear detailed insight into the collagen market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Collagen Market revenues and volume forecasts from 2019-2029

• Collagen market revenues and volume forecasts from 2019-2029 by source:
• Bovine
• Porcine
• Poultry
• Marine
• Others

Collagen Market Forecast 2019-2029

• Collagen market revenues and volume forecasts from 2019-2029 by product:
• Gelatine
• Hydrolysed Collagen
• Native
• Others

• Collagen market revenues and volume forecasts from 2019-2029 by application:
• Food & Beverages
• Healthcare
• Cosmetics
• Others

• Our analyses show individual revenue and volume forecasts from 2019-2029 for these national markets:
• The U.S.
• Canada
• Germany
• France
• The U.K.
• Italy
• China
• Japan
• India
• Thailand
• Philippines
• Brazil
• Mexico
• Chile
• South Africa
• Saudi Arabia
• Rest of World (RoW)

Each national market is further segmented by submarket.

• This report discusses the selected leading companies that are key players in the collagen market:
• Advanced BioMatrix, Inc.
• Collagen Matrix
• Collagen Solution Plc
• Cologenesis HealthCare Pvt. Ltd.
• Croda International Plc.
• JBS S.A.
• Koninklijke DSM N.V.
• Nitta Gelatin, Inc.
• PAN-Biotech GmbH
• Rousselot BV
• Shanghai Al-Amin Biotech Co.,
• Titan Biotech Ltd
• Xiamen Yiyu Biological Technology Co., Ltd.

• Our study provides qualitative analysis of the collagen market:
• Drivers and Restraints
• PEST Analysis
• Porter’s Five Forces Analysis

• Key Questions Answered by this Report:
• How is the collagen market evolving?
• What are the drivers and restraints for the growth of the collagen Market?
• How will each collagen submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each collagen submarket develop to 2029?
• What is the value of the leading collagen submarkets in important regions of the world?
• What will be the main driver for the overall market to 2029?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market by 2029?
• Who are the leading players and what are their prospects over the forecast period?

Visiongain’s study is intended for anyone requiring commercial analyses for the collagen market. You find data, trends and predictions.

Buy our report today Collagen Market Forecast 2019-2029: Revenue Prospects for Source, Product, and Application.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Collagen Market Report 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Collagen Market Report 2019-2029

Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019


“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019


“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019


“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019